Soni MedicareBOM:539378 48 EBITDA Margin % is 3.09% as of Mar. 2026, which is 25% below its 10-year median of 4.10. GuruFocus rates BOM:539378 with a GF Score™ of 48/100 and a GF Value™ of ₹30.55 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Soni Medicare ranks worse than 77.26% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Soni Medicare's EBITDA for the
three
months ended in Mar. 2026 was ₹1.8 Mil. Soni Medicare's Revenue for the
three
months ended in Mar. 2026 was ₹58.3 Mil. Therefore, Soni Medicare's EBITDA margin for the quarter that ended in Mar. 2026 was 3.09%.
Soni Medicare (BOM:539378) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Soni Medicare EBITDA Margin % Related Terms
Soni Medicare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Soni Medicare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:539378 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Soni Medicare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Soni Medicare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Soni Medicare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Soni Medicare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Soni Medicare (BOM:539378) has a EBITDA Margin % of 3.09% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Soni Medicare and its competitors. This is 25% below median its historical median of 4.10. According to the industry distribution chart, Soni Medicare ranks #513 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 77.3%.
Is Soni Medicare's EBITDA Margin % too high?
Soni Medicare's current EBITDA Margin % of 3.09% is 25% below median its 10-year median of 4.10. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Soni Medicare's value of 3.09% is 69.7% below this industry median. Based on the distribution chart, Soni Medicare ranks #513 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Soni Medicare has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Soni Medicare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Soni Medicare ranks #513 out of 664 companies for EBITDA Margin %. This places Soni Medicare in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Soni Medicare's value of 3.09% is 69.7% below this benchmark. While the company's 10-year median is 4.10 vs. the industry median of 10.21, Soni Medicare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Soni Medicare's current EBITDA Margin % of 3.09% is 69.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Soni Medicare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Soni Medicare's current EBITDA Margin % is 3.09%, which is 25% below median its own 10-year median of 4.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Soni Medicare stock overvalued right now?
Based on GuruFocus' analysis, Soni Medicare (BOM:539378) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹30.55, compared to a current price of ₹70.20 — trading 129.8% above its estimated fair value. The current EBITDA Margin % is 3.09%, which is 25% below median its 10-year median of 4.10 and 69.7% below the Healthcare Providers & Services industry median of 10.21. Soni Medicare's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Soni Medicare (BOM:539378), the current EBITDA Margin % is 3.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Soni Medicare (BOM:539378) Overvalued in 2026?
Based on GuruFocus' analysis, Soni Medicare stock appears to be overvalued.
The current stock price of ₹70.20 is trading 129.8% above its estimated GF Value™ of ₹30.55.
GuruFocus considers Soni Medicare to be Significantly Overvalued.
Key valuation signals for BOM:539378:
EBITDA Margin %: 3.09% (25% below median its 10-year median of 4.10)
GF Value™: ₹30.55 vs. price of ₹70.20 (129.8% above fair value)
Industry Position: 69.7% below the Healthcare Providers & Services median (#513 of 664)
No single metric tells the full story. See the BOM:539378 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Soni Medicare Ltd is an India-based company engaged in providing human health services. It provides services like education and courses, health check-ups, patient counseling, outpatient services, inpatient services, emergency care, intensive care unit, dialysis centers, operation theatre, laboratory services, physiotherapy, blood bank, oncology, pharmacies, radiology services, and orthopedic services. The company generates its revenue from providing super specialty and general hospital services.
48GF Score
Get the complete analysis for BOM:539378
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539378 has been successfully added to your 
